Corporate
A scientifically rigorous CRO built for complex preclinical decision-making
Pharmidex operates at the interface of discovery, translational science, and regulatory development.
Our role is not simply to execute studies, but to help sponsors reduce risk, interpret results, and move forward with clarity.
Our Role in Development
Drug development often fails due to poor decisions made on incomplete or misinterpreted data.
We focus on generating data that:
- stands up to regulatory scrutiny
- supports clear progression decisions
- reduces downstream risk
Scientific Depth
Pharmidex is structured around senior scientific leadership, not volume-driven execution.
Our expertise includes:
- CNS, oncology, metabolic, and respiratory research
- In vivo pharmacology and translational models
- ADME, PK, and exposure-response analysis
- GLP bioanalysis and safety support
Experience & credibility
- 17,000+ studies delivered
- 400+ global clients
- Extensive UK and EU grant programme involvement
Quality & compliance
Our work is supported by robust QA systems aligned with GLP, GCP, and regulatory expectations.
We combine compliance with flexibility to deliver reliable, high-quality data.
Pharmidex facilities are accredited by:
Pharmidex are a proud member of:
Engage With Us
If you are seeking a CRO partner who combines scientific judgement, regulatory awareness, and integrated delivery, we welcome the opportunity to discuss your programme.
➡️
Start a conversation with our scientific team
